Comparing the quality of pro- and anti-vaccination online information: a content analysis of…

The exponential increase in health-related online platforms has made the Internet one of the main sources of health information globally.


Two Vaccines for One Polio-free World

Lee Hampton, MD, Medical Officer, Vaccine Introduction Team, Global Immunization Division Polio was once considered one of the most frightening diseases in the world until a team led by Dr. Jonas Salk developed the first successful polio vaccine. World Polio Day, held every October 24 to celebrate Salk’s birthday, is an opportunity for everyone working to eradicate polio to renew their commitment to creating a polio-free world for future generations. Today most of the world is polio-free, but the disease continues to disable children in some countries. And as long as polio exists anywhere, the disease remains a threat everywhere.

World map

First MERS vaccine heads for human trials

Firms plan to take on research after tests show vaccine protects monkeys from Middle East respiratory syndrome.


WHO Speculates On Timelines For Experimental Zika Vaccine, Conclusions On Possible Links To…

Associated Press: WHO: possible Zika vaccines months away from broad trials “The World Health Organization says possible Zika vaccines are at least 18 months away from large-scale trials. WHO assistant director-general for health systems and innovation Marie-Paule Kieny says the U.N. health agency’s response is ‘proceeding very quickly’ and 15 companies or groups have been…More

Return On Investments In Childhood Vaccines Can Be High In LMICs, Study Shows

Quartz: A new study confirms that spending $1 on childhood vaccines can save $44 in future savings, in poor countries “…This month in Health Affairs, a team of U.S. public health and data specialists calculated the costs and economic benefits associated with distributing childhood vaccines for diseases in 94 low- and middle-income countries. The study,…More

Global Community Must Coordinate Efforts To Eradicate Polio

New England Journal of Medicine: A World Free of Polio — The Final Steps Manish Patel, member of the Task Force for Global Health, and Walter Orenstein, associate director of the Emory Vaccine Center “…[In the process of removing all oral polio vaccines (OPVs) over the long term, c]oordinated communication among global health organizations, countries,…More

Communication strategies to promote the uptake of childhood vaccination in Nigeria: a…

Background: Effective communication is a critical component in ensuring that children are fully vaccinated.

Wider Use Of Vaccines Instead Of Antibiotics Would Help Lower Drug Resistance, Antimicrobial…

Financial Times: O’Neill ‘superbug’ review promotes wider use of vaccines “Vaccines should be used more widely in health care and agriculture as an alternative to antibiotics, according to a U.K.-led review into the problem of drug-resistant ‘superbugs.’ Lord Jim O’Neill, the Treasury minister and former Goldman Sachs economist heading the panel, said vaccines were a…More

Vaccines Hold Potential To Protect Against Drug Resistance

Project Syndicate: Vaccines Versus Superbugs Jim O’Neill, commercial secretary to the U.K. Treasury, honorary professor of economics at Manchester University, visiting research fellow at Bruegel, and chair of the Review on Antimicrobial Resistance. “…[W]e are not moving fast enough to develop the types of vaccines that could be used to prevent antimicrobial resistance. … Maximizing…More

Health Affairs Studies Explore Return On Investment, Financing Of Vaccines

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Vaccines: The Best Shot for Children and Economies Logan Brenzel, senior program officer on the vaccine delivery team at the Bill & Melinda Gates Foundation, discusses the February issue of Health Affairs, which explores the return on investment, costs, and financing of immunizations (2/9).

No Shot: US Vaccine Prices And Shortages [Economics Of Vaccines]

In 2004 an Institute of Medicine report warned of vaccine shortages, raising concerns about disease outbreaks.

Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits…

Vaccinating females against human papillomavirus (HPV) prior to the debut of sexual activity is an effective way to prevent cervical cancer, yet vaccine uptake in low- and middle-income countries has been hindered by high vaccine prices.

Experts See Barriers In Current Vaccine R&D System for Zika, Other Neglected Diseases,…

International Business Times: Zika Vaccine: Why Developing One Will Take Years In A Skewed System “…[T]he world of vaccine development has grown vastly more complicated, to a point where critics describe it as failing to meet the needs of public health in a timely fashion. Nowhere has this gap become more apparent than in the…More

Inactivated polio vaccine introduction in south Asia—1 year on

In 2014, the Global Polio Eradication Initiative advised introducing one dose of inactivated polio vaccine (IPV) in countries not already using it. The introduction of IPV, which contains inactivated forms of poliovirus, aims to mitigate the small risk of mainly type 2 live attenuated poliovirus in the oral polio vaccine (OPV), causing vaccine-associated paralytic poliomyelitis and vaccine-derived poliovirus. In September, 2014, Nepal was the first country supported by GAVI to introduce IPV. Since this launch all countries in south Asia (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka) have introduced IPV.

Sanofi Pasteur Hopes Work On Dengue Vaccine Will Inform Zika Research; Vaccine Candidate…

Bloomberg Business: Sanofi’s Brandicourt Pushes for Speedy Zika Vaccine Development “Sanofi Chief Executive Officer Olivier Brandicourt is pushing for speedy development of a Zika virus vaccine, building on the company’s success in bringing the first inoculation against dengue to market. Sanofi could start testing a vaccine candidate in people as early as next year, Brandicourt…More

Taming the fear of voice: Dilemmas in maintaining a high vaccination rate in the Netherlands

Publication date: March 2016 Source:Social Science & Medicine, Volume 153 Author(s): Els Geelen, Hans van Vliet, Pieter de Hoogh, Klasien Horstman In the context of international public debates on vaccination the National Institute for Public Health and the Environment (RIVM), the Dutch public health body responsible for the National Immunization Programme (NIP), fears that the high vaccination rate of children in the Netherlands obscures the many doubts and criticisms parents may have about vaccination.

Vaccines: The Best Shot for Children and Economies

Go here to see the original: Vaccines: The Best Shot for Children and Economies

Older Posts »